Bharat Serums and Vaccines has received approval from the Subject Expert Committee (SEC) functional under the Central Drugs ...

For high-risk patients with type 2 diabetes, oral semaglutide reduced risk for major cardiovascular and ischemic limb-related ...

New findings reveal RG6501 cell therapy shows promising long-term visual improvements for geographic atrophy patients ...

W. Timothy Garvey, M.D., served as lead author in the clinical trial. A new combination drug therapy is showing extraordinary ...

A Forrester study reveals that nearly half of U.S. healthcare organizations are deploying AI to improve workflow efficiency.

Edgewise Therapeutics (NASDAQ:EWTX) lost ~9% in the morning hours on Thursday after the company posted data from clinical ...